HCA Healthcare, Inc. (HCA)
| Previous Close | 321.89 |
| Open | 322.89 |
| Bid | 325.55 x 800 |
| Ask | 325.69 x 900 |
| Day's Range | 322.20 - 326.23 |
| 52 Week Range | 215.96 - 335.83 |
| Volume | |
| Avg. Volume | 1,036,479 |
| Market Cap | 85.345B |
| Beta (5Y Monthly) | 1.67 |
| PE Ratio (TTM) | 16.25 |
| EPS (TTM) | 20.05 |
| Earnings Date | Jul 25, 2024 - Jul 29, 2024 |
| Forward Dividend & Yield | 2.64 (0.82%) |
| Ex-Dividend Date | Jun 14, 2024 |
| 1y Target Est | 347.65 |
ZacksHere's Why HCA Healthcare (HCA) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
GlobeNewswireAREX Capital Expresses Disappointment in Enhabit’s Strategic Review Conclusion
Believes Enhabit’s Shares Do Not Reflect its Intrinsic Value or Strategic Potential Has Nominated Seven Highly Qualified Independent Directors Believes AREX Slate Would Provide Board With Sorely Needed Home Health and Hospice Expertise NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- AREX Capital Management, LP (“AREX Capital Management” or “we”), together with its affiliates, the owners of approximately 4.8% of the shares of Enhabit, Inc. (NYSE: EHAB) (the “Company” or “Enhabit”), today issued the be
GuruFocus.comInsider Sale: EVP and Chief Clinical Officer Michael Cuffe Sells 1,600 Shares of HCA Healthcare ...
On May 6, 2024, Michael Cuffe, EVP and Chief Clinical Officer of HCA Healthcare Inc (NYSE:HCA), sold 1,600 shares of the company.
